We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CureVac Gets Green Light to Start COVID-19 Vaccine Trial
CureVac Gets Green Light to Start COVID-19 Vaccine Trial
CureVac has won approval in Germany and Belgium for a phase 1 trial of its COVID-19 vaccine, just days after the German government announced it was acquiring a 23 percent stake in the company.